Funding
Proximal Ventures raises debut fund to back startups bringing AI to drug development (opens techcrunch.com)
Former SignalFire investor Sahir Raoof's first fund targets AI in pharma.
Former SignalFire investor Sahir Raoof's first fund targets AI in pharma.
Oura buys Counsel Health for $625M weeks after postponing its own IPO; Oura added Counsel's AI chatbot to its app earlier this year.
We help the labs behind your medicines deliver study results 10x faster.
The Alphabet-owned AI drug discovery company would raise roughly $5B at about a $50B valuation, after a $2.1B round in May.
Opentrons will use the money to scale its lab robotics, software and data infrastructure.